The partnership aims to provide game-changing luminescent lanthanide-based oligo probes for diagnostics and life science research applications. MORRISVILLE, N.C. and…
Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reduction in sorbitol maintained through…
Medical Advisory Board additions support company’s growing product offerings across women’s health and family building NEW YORK, May 14, 2025…
IRVINE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, developer of GlutenID, the first and only U.S. Food…
Study presented at DDW 2025 finds genetic risk scores can identify patients at higher risk of nausea from GLP-1 therapies,…
In the rapidly evolving landscape of oncology, precision is the cornerstone of progress. A leading biopharmaceutical company specializing in non-small…
PHILADELPHIA, April 24, 2025 (GLOBE NEWSWIRE) -- The Love for Liam Foundation, a 501(c)(3) nonprofit that seeks to raise awareness…
APEA platform recognized for transforming real-time policy enforcement and powering smarter diagnostics decisions TAMPA, Fla., April 16, 2025 /PRNewswire/ --…
Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases…
Setting the standard through dynamic genomic technology platform, improving patient outcomes AURORA, Colo., March 12, 2025 /PRNewswire/ -- The Children's…